Restructuring, Weak Dollar Prompts Wells Fargo to Upgrades St. Jude Medical (STJ) to Outperform

September 19, 2012 6:54 AM EDT Send to a Friend
Get Alerts STJ Hot Sheet
Price: $45.15 -0.04%

Rating Summary:
    10 Buy, 10 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 18 | New: 13
Trade STJ Now!
Analysts at Wells Fargo upgraded cardiovascular medical devices company, St. Jude Medical (NYSE: STJ) to Outperform from Market Perform. St. Jude Medical stock has been extremely resilient despite safety concerns with its Riata/Durata ICD leads.

Analysts said the noise level on Durata should subside over the next 6-9 months and lofty expectations for its pipeline have come down but several near-term pipeline products should contribute in 2013. Additionally the recent restructuring and a weaker dollar should lead to upside potential in the second half of 2012 and 2013.

Analysts increased their price target on STJ to $49.00 to $50.00 from $40.00 to $41.00.

For an analyst ratings summary and ratings history on St. Jude Medical click here. For more ratings news on St. Jude Medical click here.

Shares of St. Jude Medical closed at $42.90 yesterday, with a 52 week range of $32.13-$44.80.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change, Upgrades

Related Entities

Wells Fargo

Add Your Comment